﻿<?xml version="1.0" encoding="UTF-8"?>
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>Tabriz University of Medical Sciences</PublisherName>
      <JournalTitle>BioImpacts</JournalTitle>
      <Issn>2228-5652</Issn>
      <Volume>14</Volume>
      <Issue>5</Issue>
      <PubDate PubStatus="ppublish">
        <Year>2024</Year>
        <Month>09</Month>
        <DAY>01</DAY>
      </PubDate>
    </Journal>
    <ArticleTitle>Systemic nitric oxide metabolites and the chance of pre-diabetes regression to normoglycemia: A 9-year cohort study</ArticleTitle>
    <FirstPage>29917</FirstPage>
    <LastPage>29917</LastPage>
    <ELocationID EIdType="doi">10.34172/bi.2024.29917</ELocationID>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Zahra</FirstName>
        <LastName>Bahadoran</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0002-5138-0045</Identifier>
      </Author>
      <Author>
        <FirstName>Parvin</FirstName>
        <LastName>Mirmiran</LastName>
      </Author>
      <Author>
        <FirstName>Fereidoun</FirstName>
        <LastName>Azizi</LastName>
      </Author>
      <Author>
        <FirstName>Asghar</FirstName>
        <LastName>Ghasemi</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0001-6867-2151</Identifier>
      </Author>
    </AuthorList>
    <PublicationType>Journal Article</PublicationType>
    <ArticleIdList>
      <ArticleId IdType="doi">10.34172/bi.2024.29917</ArticleId>
    </ArticleIdList>
    <History>
      <PubDate PubStatus="received">
        <Year>2023</Year>
        <Month>05</Month>
        <Day>28</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2024</Year>
        <Month>01</Month>
        <Day>02</Day>
      </PubDate>
    </History>
    <Abstract>Introduction: We aimed to track longitudinal changes of glycemic status in subjects with pre-diabetes (Pre-DM) in relation to their baseline levels of systemic nitric oxide (NO) production [i.e., measured as serum NO metabolites (NOx), crude and body weight (BW)-adjusted NOx to creatinine ratio (NOx-to-Cr)] over 9 years. Methods: This cohort study included 541 middle-aged Iranian men and women with Pre-DM, recruited in 2006-2008 and followed up to 2015-2017. The colorimetric Griess method was used to measure serum NOx concentration. Multinomial logistic regression analyses estimated the odds ratios (OR) of Pre-DM regression and progression across tertiles (tertile 3 vs. tertile 1 and tertile 2) of serum NOx, crude, and BW-adjusted NOx-to-Cr ratio. Results: Participants who regressed to normoglycemia (NG) had a higher BW-adjusted NOx-to-Cr ratio than those who developed type 2 diabetes (T2D) or those who remained Pre-DM (0.52±0.34 vs. 0.43±0.25 and 0.48±0.29, P=0.023). Higher BW-adjusted NOx-to-Cr increased chance of returning to NG (OR=2.05, 95% CI= 0.98-4.32, P=0.058) and decreased levels of 2h-serum glucose over time (Ptime×group=0.025), as well as the decreased overall mean of fasting (106, 95% CI=103-109 vs. 110, 95% CI=108-112 mg/dL, P=0.008) and 2h-serum glucose (153, 95% CI=146-159 vs. 163, 95% CI=158-168 mg/dL, P=0.018). Conclusion: A higher endogenous NO production (i.e., indirectly measured by BW- and Cr-adjusted serum NOx concentration) in Pre-DM subjects is associated with the chance of returning to NG.</Abstract>
    <ObjectList>
      <Object Type="keyword">
        <Param Name="value">Nitric oxide</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Pre-diabetes</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Type 2 diabetes</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Normoglycemia</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Griess method</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Glycemic status</Param>
      </Object>
    </ObjectList>
  </Article>
</ArticleSet>